Not all Big Pharma's businesses in emerging markets are doing so well, Fosun is buying a smaller stake in Gland, Taiho and Arcus ink cancer option deal.
German drugmaker Stada has announced plans to sell itself for €5.32 billion ($5.63 billion) shortly after weighing a $3.7 billion private equity takeout.
China's Shanghai Fosun Pharmaceuticals has reportedly won a bidding war for India's privately held injectable maker Gland Pharma in a rare cross-border deal.
China’s Shanghai Fosun Pharmaceutical has made it official. It wants to expand its sterile manufacturing capabilities and has made a bid for India’s Gland Pharma.